As of 2025-08-27, the Intrinsic Value of PMV Pharmaceuticals Inc (PMVP) is -7.78 USD. This PMVP valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.44 USD, the upside of PMV Pharmaceuticals Inc is -640.53%.
Based on its market price of 1.44 USD and our intrinsic valuation, PMV Pharmaceuticals Inc (PMVP) is overvalued by 640.53%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.78 - -7.78 | -7.78 | -640.53% |
| P/E | (31.45) - (36.58) | (37.09) | -2675.6% |
| DDM - Stable | (9.47) - (22.61) | (16.04) | -1214.0% |
| DDM - Multi | (5.93) - (11.21) | (7.78) | -640.2% |
| Market Cap (mil) | 74.81 |
| Beta | 0.36 |
| Outstanding shares (mil) | 51.95 |
| Enterprise Value (mil) | 30.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.85% |
| Cost of Debt | 5.00% |
| WACC | 8.93% |